Owen Durham

Owen Durham is an accomplished engineering professional with extensive experience in process engineering and validation within the pharmaceutical and biotechnology sectors. Currently serving as Associate Director of Process Engineering at EyePoint Pharmaceuticals since April 2021, Owen has held various roles including Sr. Process Engineer and Validation Engineer IV and III at CRISPR Therapeutics from December 2019 to April 2021. Prior experience includes a supervisory position at Boston Scientific where responsibilities encompassed process and manufacturing engineering, alongside roles at Eastek International, DuPont Titanium Technologies, and Metalor Technologies SA, focusing on co-op positions in engineering. Educational qualifications include a degree from Northeastern University completed in 2016, complemented by foundational experiences at Madison High School.